IMB-YH-8

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIMB-YH-8
Drug Alias NameMycobacterium tuberculosis protein kinase B inhibitors (Chinese Academy of Medical Sciences)B12-2IMB-YH-8
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionProto-oncogene proteins c-akt inhibitors
TargetsProto-oncogene proteins c-akt
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChinese Academy Of Medical Science & Peking Union Medical College
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChinese Academy Of Medical Science & Peking Union Medical College
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A